IPO registrations (S-1, F-1) · Registrants
Glucotrack, Inc.
- SEC CIK
- 1506983 · filings on EDGAR ↗
- Former names
- Integrity Applications, Inc. (2010–2021)
- Registration
- Form S-1, first filed 2011-08-22, last 2026-10-14; 7 initial registrations, 13 amendments
- Outcome
- Final prospectus filed 2024-11-14; declared effective 2011-11-14; withdrawal requested 2013-01-16
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 301 RT 17 NORTH, SUITE 800, Rutherford, NJ 07070
- EIN
- 98-0668934
- Ticker
- GCTK (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Glucotrack, Inc. on the corporate pages
Offering terms
- Final price
- $1.39 per share (424B4 filed 2024-11-14)
- Shares sold
- 4,756,900
- Gross proceeds
- $6,612,091 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol GCTK
- Lead underwriters
- James Securities, Inc
- Syndicate
- of Contents; Dawson James
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: GLUCOTRACK INC Fuzzy (name and state)
- Form D issuer: GlucoTrack, Inc. EXACT (CIK (EXACT))
- SEC filer: Glucotrack, Inc. EXACT (CIK (EXACT))
- Person page: James S Cardwell Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 35
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-08-22 | S-1 | S-1 (registration) | Integrity Applications, Inc. | 0001144204-11-048873 ↗ |
| 2011-10-07 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001144204-11-056920 ↗ |
| 2011-10-27 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001144204-11-059593 ↗ |
| 2011-11-10 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001144204-11-062924 ↗ |
| 2011-11-14 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-11-003288 ↗ |
| 2013-01-16 | RW | RW (withdrawal request) | Integrity Applications, Inc. | 0001178913-13-000106 ↗ |
| 2013-04-29 | S-1 | S-1 (registration) | Integrity Applications, Inc. | 0001178913-13-001249 ↗ |
| 2013-05-13 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001178913-13-001476 ↗ |
| 2013-05-14 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001178913-13-001489 ↗ |
| 2013-05-14 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-13-001524 ↗ |
| 2014-05-02 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-14-001305 ↗ |
| 2015-03-31 | S-1 | S-1 (registration) | Integrity Applications, Inc. | 0001178913-15-001122 ↗ |
| 2015-04-15 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-15-000895 ↗ |
| 2016-07-15 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-16-005171 ↗ |
| 2016-07-15 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-16-005172 ↗ |
| 2017-11-07 | S-1 | S-1 (registration) | Integrity Applications, Inc. | 0001178913-17-003057 ↗ |
| 2017-12-08 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001178913-17-003349 ↗ |
| 2017-12-21 | S-1/A | S-1/A (amendment) | Integrity Applications, Inc. | 0001178913-17-003449 ↗ |
| 2017-12-26 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-17-003322 ↗ |
| 2018-06-28 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-18-001666 ↗ |
| 2021-09-27 | EFFECT | EFFECT (declared effective) | Integrity Applications, Inc. | 9999999995-21-003672 ↗ |
| 2024-09-16 | S-1 | S-1 (registration) | Glucotrack, Inc. | 0001493152-24-036440 ↗ |
| 2024-10-03 | EFFECT | EFFECT (declared effective) | Glucotrack, Inc. | 9999999995-24-003086 ↗ |
| 2024-10-24 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-24-042366 ↗ |
| 2024-11-04 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-24-043401 ↗ |
| 2024-11-08 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-24-044183 ↗ |
| 2024-11-08 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-24-044347 ↗ |
| 2024-11-12 | EFFECT | EFFECT (declared effective) | Glucotrack, Inc. | 9999999995-24-003452 ↗ |
| 2024-11-14 | 424B4 | 424B4 (final prospectus) | Glucotrack, Inc. | 0001493152-24-045365 ↗ |
| 2025-09-29 | S-1 | S-1 (registration) | Glucotrack, Inc. | 0001493152-25-016051 ↗ |
| 2025-10-08 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-25-017452 ↗ |
| 2026-01-27 | EFFECT | EFFECT (declared effective) | Glucotrack, Inc. | 9999999995-26-000318 ↗ |
| 2026-04-30 | EFFECT | EFFECT (declared effective) | Glucotrack, Inc. | 9999999995-26-001400 ↗ |
| 2026-09-18 | S-1 | S-1 (registration) | Glucotrack, Inc. | 0001493152-26-043195 ↗ |
| 2026-10-14 | S-1/A | S-1/A (amendment) | Glucotrack, Inc. | 0001493152-26-046915 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | S-1/A | registration statement | 7,462,686 | - | Nasdaq GCTK | 5 | primary document; shares headline, cover names 5 | document ↗ | ||
| 2024-11-08 | S-1/A | registration statement | $6.30 | - | - | 0 | primary document; price sentence | document ↗ | ||
| 2024-11-14 | 424B4 | final prospectus | $1.39 | 4,756,900 | $6,612,091 | Nasdaq GCTK | 3 | primary document; price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bar-Shalom Jacob | Officer | Chief Financial Officer | 1 | 2012 | |
| Cohen Zvi | Director | 2 | 2012–2015 | ||
| Gal Avner | Director,Officer | Chairman and CEO | 2 | 2012–2015 | |
| Malka David | Director,Officer; Officer | Vice President of Operations | 3 | 2012–2017 | |
| Fischell Robert | Director | 5 | 2012–2025 | ||
| Gold Joel L | Director | 1 | 2012 | ||
| Ehrlich Israel B. | Director | 1 | 2013 | ||
| Hertz Eran | Officer | Chief Financial Officer | 2 | 2014–2015 | |
| BOYDSTON ANGELA STRAND | Director; Director,Officer | Interim Chief Strategy Officer | 4 | 2016–2017 | |
| Seff Leslie | Director | 5 | 2016–2017 | ||
| SCHWARTZ REVAN | Director | 4 | 2016–2017 | ||
| Darivoff Philip | Director | 5 | 2016–2017 | ||
| SASSOUN SAMI | Officer | Chief Financial Officer | 1 | 2017 | |
| GRAHAM JOHN A | Director,Officer | Chief Executive Officer | 2 | 2017 | |
| Hauck Michael | Director | 2 | 2017 | ||
| podwalski david | Officer | Chief Commercial Officer | 2 | 2017 | |
| SYCOFF DREW | Director; Director,TenPercentOwner | 3 | 2019–2024 | ||
| Rapps Shimon D | Director | 1 | 2019 | ||
| Danzig Allen | Director | 2 | 2022–2025 | ||
| Carter Erin Catherine | Director | 3 | 2023–2025 | ||
| Cardwell James S | Officer | Chief Financial Officer | 1 | 2023 | person page Fuzzy |
| Goode Paul | Director,Officer; Officer | Chief Executive Officer | 4 | 2024–2025 | |
| BALLANTYNE JOHN | Director,TenPercentOwner | 2 | 2024–2025 | ||
| Wulff Peter C | Officer | Chief Financial Officer | 1 | 2025 | |
| Balo Andrew K | Director | 3 | 2025 | ||
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | 2 | 2025 | ||
| Malave Luis | Director | 3 | 2025 | ||
| CARR BRENDEL VICTORIA | Director | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-05-08 | GlucoTrack, Inc. | Biotechnology | $500,000 | $500,000 | 9 | 1 |
| 2020-02-28 | Integrity Applications, Inc. | Biotechnology | $15,000,000 | $15,000,000 | 1 | 1 |
| 2017-12-11 | Integrity Applications, Inc. | Other Health Care | $10,000,000 | $425,000 | 6 | 1 |
| 2016-04-18 | Integrity Applications, Inc. | Other Health Care | $12,000,000 | $11,003,800 | 96 | 3 |
| 2014-09-12 | Integrity Applications, Inc. | Other Health Care | $8,500,000 | $3,036,000 | 31 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | GLUCOTRACK INC | NJ | State business registries | name and state |
| Form D issuer | GlucoTrack, Inc. | NJ | Form D private offerings | CIK (EXACT) |
| SEC filer | Glucotrack, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Glucotrack, Inc. | NJ | Trademarks (USPTO) | name and state |
| Person page | James S Cardwell | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NJ first:
- ANTARES PHARMA, INC. NJ
- INTERPACE BIOSCIENCES, INC. NJ
- Cytosorbents Corp NJ
- NEPHROS INC NJ
- NUCRYST Pharmaceuticals Corp. NJ
- BAETA CORP NJ
- VALERITAS INC NJ
- Turnpoint Medical Devices, Inc. NJ
- Valeritas Holdings Inc. NJ
- CHP Merger Corp. NJ
In other datasets, the same topic (Technology) in NJ:
- Form D issuer: A2Zlogix, Inc. (Form D private offerings)
- Lobbying client: 1KOSMOS INC (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology